z-logo
open-access-imgOpen Access
Superficial Siderosis and Anticoagulation Therapy: Different Presentations, Different Outcomes
Author(s) -
Rui Barreto,
Luís Ruano,
Vítor Tedim Cruz,
Carlos Veira,
Paula Coutinho
Publication year - 2012
Publication title -
case reports in neurological medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6668
pISSN - 2090-6676
DOI - 10.1155/2012/745430
Subject(s) - superficial siderosis , medicine , siderosis , magnetic resonance imaging , brainstem , pediatrics , etiology , cognitive decline , ataxia , cerebral amyloid angiopathy , surgery , pathology , radiology , dementia , psychiatry , disease
Superficial siderosis is a potentially manageable neurodegenerative disorder, caused by chronic subarachnoid haemorrhage and iron deposition along the central nervous system surfaces. Association with oral anticoagulant therapy is well known, but its definite role as a causative agent is yet to be clarified. Two Caucasian women, both under long-term oral anticoagulation: a 74 year old woman with slowly progressive hearing loss and mild cerebellar ataxia; a 72 year old woman suffering from behavioural changes, rapidly progressive cognitive decline and latter developing paraparesis. Magnetic resonance imaging showed striking hypointensities along the surfaces of cerebellum, brainstem, frontotemporal cortices, spinal cord, and lumbar arachnoid therefore suggesting superficial siderosis. No specific bleeding source was found in any of the patients. Anticoagulation could not be stopped in the first patient due to a mechanic valve and slowly progressive worsening occurred. In contrast, for the second patient anticoagulation withdrawal was feasible and marked motor and cognitive improvement ensued. Superficial siderosis is associated with unvarying progression, mostly when no direct source of bleeding is identified. Nonetheless, we verified striking motor and cognitive improvement after anticoagulants withdrawal in one of the patients. This may reinforce the need to consider such modifiable factor in future patient management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom